Summary
A new aldose reductase inhibitor, (E)-3-carboxy-methyl-5-[(2E-methyl-3-phenylpropenylidene]rhodanine (ONO-2235) was administered orally to streptozotocin-diabetic rats (60 mg/kg IV) for 14 days and its effect on motor nerve conduction velocity studied. The compound significantly improved motor nerve conduction velocity of diabetic rats at a minimal dose of 10 mg · kg-1 · day-1 (treated 28.8±0.5 versus untreated 23.2±4.7 m/s, p < 0.01). The sorbitol content of the sciatic nerve and red blood cells measured after 2 weeks was concomitantly reduced in ONO-2235-treated rats (sciatic nerve: 120±13 versus 595±146 nmol/g wet weight; red blood cell: 91±21 versus 165±39 nmol/g haemoglobin; p < 0.01 in both 20 mg · kg-1 · day-1-treated versus untreated animals). These results suggest that sorbitol accumulation might contribute to the development of peripheral nerve dysfunction in acutely diabetic animals and the new aldose reductase inhibitor could be a potential drug for therapy of diabetic neuropathy.
Article PDF
Similar content being viewed by others
References
Stewart MA, Sherman WR, Anthony S (1966) Free sugars in alloxan diabetic rat nerve. Biochem Biophys Res Commun 22: 488–491
Gabbay KH (1973) The sorbitol pathway and the complications of diabetes. N Engl J Med 288: 831–836
Dvornik D, Simard-Duquesne N, Krami M, Sestanj K, Gabbay KH, Kinoshita JH, Varma SD, Merola O (1973) Polyol accumulation in galactosemic and diabetic rats: control by an aldose reductase inhibitor. Science 182: 1146–1148
Peterson MJ, Sarges R, Aldinger CE, MacDonald DP (1979) CP-45,634: A novel aldose reductase inhibitor that inhibits polyol pathway activity in diabetic and galactosemic rats. Metabolism 28: 456–461
Handelsman DJ, Turtle JR (1981) Clinical trial of an aldose reductase inhibitor in diabetic neuropathy. Diabetes 30: 459–464
Judzewitsch R, Jaspan JB, Pfeifer MA, Polonsky KS, Halar E, Vukadinovic C, Richton S, Gabbay K, Rubenstein AH, Porte DJr (1981) Inhibition of aldose reductase improves motor nerve conduction velocity in diabetics. Diabetes 30, Suppl 1: 118 (Abstract)
Greene DA, Lewis RA, Lattimer SA, Brown MJ (1982) Selective effects of myo-inositol administration on sciatic and tibial motor nerve conduction parameters in the streptozotocin-diabetic rat. Diabetes 31: 573–578
Miyoshi T, Goto I (1973) Serial in vivo determinations of nerve conduction velocity in rat tails: physiological and pathological change. Electroencephalogr Clin Neurophysiol 35: 125–131
Thomas PK, Jefferys JGR, Sharma AK, Bajada S (1981) Nerve conduction velocity in experimental diabetes in the rat and rabbit. J Neurol Neurosurg Psychiatr 44: 233–238
Kikkawa R, Hatanaka I, Kobayashi N, Yasuda H, Shigeta Y (1982) The effect of aldose reductase inhibitor (sorbinil) and methylcobalamin on peripheral nerve disorders in streptozotocindiabetic rats. In: Goto Y, Horiuchi A, Kogure K (eds) Proceedings of the International Symposium on Diabetic Neuropathy and Its Treatment, Tokyo. Excepta Medica, Amsterdam, International Congress Series 581: 350–354
Bergmeyer HV, Gruber W, Gutamann I (1974) D-Sorbitol. In: Bergmeyer HV (ed) Methods of enzymatic analysis, Academic Press, New York, pp 1323–1326
Malone JI, Knox G, Benford S, Tedesco TA (1980) Red cell sorbitol. An indicator of diabetic control. Diabetes 29: 861–864
Greene DA, De Jesus PV, Winegrad AI (1975) Effects of insulin and dietary myoinositol on impaired peripheral motor nerve conduction velocity in acutely streptozotocin diabetes. J Clin Invest 55: 1326–1336
Kador HP, Kinoshita JH, Tung WH, Chylack LT (1980) Differences in the susceptibility of various aldose reductases to inhibition. Invest Ophthalmol Vis Soc 19: 980–982
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kikkawa, R., Hatanaka, I., Yasuda, H. et al. Effect of a new aldose reductase inhibitor, (E)-3-carboxymethyl-5-[(2E)-methyl-3-phenylpropenylidene]rhodanine (ONO-2235) on peripheral nerve disorders in streptozotocin-diabetic rats. Diabetologia 24, 290–292 (1983). https://doi.org/10.1007/BF00282716
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00282716